An Israeli company that develops medical treatments using helpful bacteria to fight cancer and other diseases has raised $20 million.
Biomica identifies and selects microbes to treat specific diseases that will enhance how the body’s immune system responds.
It develops microbiome-based therapies for antibiotic-resistant bacteria, immuno-oncology (treatments that help the body’s immune system fight cancer), and bacteria-related gastrointestinal disorders.
Its first therapeutic – BMC128 – is currently being tested to demonstrate the effect of beneficial microbes on the immune system in its fight against cancer.
The human gut microbiome is the collection of trillions of microorganisms that exist in the digestive tract. These microbes play key roles in various functions in human health, including food digestion and protection from diseases.
Numerous studies have shown that changes in the microbiome and their interactions with immune systems, alongside other systems in the human body, are correlated with a wide array of illnesses, ranging from inflammatory bowel disease (IBD) to cancer.
The search for microbiome therapies and treatments is rapidly growing, with the potential to reach $9.9 billion annual sales by 2024.
Biomica’s investment round was led by Shanghai Healthcare Capital (SHC), in its first investment outside China.
“Biomica has made tremendous progress in the past year. This includes the initiation of the first in-human phase 1 immune-oncology clinical trial of BMC128 as well as advancing our infectious and gastrointestinal-related disease programs, said Dr. Elran Haber, CEO of Biomica.
“We look forward to working closely with our shareholders, as we continue our advancements and meet our milestones in the coming years.”
Biomica was established in 2017, and is a subsidiary of Evogene, a biotechnology company that develops new products for human health and agriculture. It is based in Rehovot, central Israel.
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors

Ashdod Port Investing In Startups As Part Of Innovation Strategy

Facebook comments